Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-24-000715

CHIEF EXECUTIVE OFFICER gave up 49,198 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bisker-Leib Vered CHIEF EXECUTIVE OFFICER 2024-02-08 Shares withheld for taxes −49,198 $1.45 $71,337 3,124,426 D
Loading xslF345X05/ownership.xml…